Remdesivir Versus Standard-of-Care for Severe Coronavirus Disease 2019 Infection: An Analysis of 28-Day Mortality.

Autor: Olender, Susan A1 (AUTHOR), Walunas, Theresa L2 (AUTHOR), Martinez, Esteban3 (AUTHOR), Perez, Katherine K4 (AUTHOR), Castagna, Antonella5 (AUTHOR), Wang, Su6 (AUTHOR), Kurbegov, Dax7 (AUTHOR), Goyal, Parag8 (AUTHOR), Ripamonti, Diego9 (AUTHOR), Balani, Bindu10 (AUTHOR), Rosa, Francesco G De11,12,13 (AUTHOR), Wit, Stéphane De14 (AUTHOR), Kim, Shin-Woo15 (AUTHOR), Diaz, George16 (AUTHOR), Bruno, Raffaele17 (AUTHOR), Mullane, Kathleen M18 (AUTHOR), Lye, David Chien19,20,21 (AUTHOR), Gottlieb, Robert L22,23 (AUTHOR), Haubrich, Richard H24 (AUTHOR) Richard.Haubrich@gilead.com, Chokkalingam, Anand P24 (AUTHOR)
Zdroj: Open Forum Infectious Diseases. Jul2021, Vol. 8 Issue 7, p1-9. 9p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje